APP(Sw) transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 9, 1997, Pages 965-973

  Irizarry, Michael C ^a   McNamara, Megan ^a   Fedorchak, Kerri ^a   Hsiao, Karen ^b   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alzheimer disease; Amyloid precursor protein; Amyloid protein; Hippocampus; mRNA; Synaptophysin; Transgenic models

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MESSENGER RNA; SYNAPTOPHYSIN;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DENTATE GYRUS; DYSTROPHY; GENE EXPRESSION; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NEURITE; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CELL COUNT; GENETICS; HUMAN; METABOLISM; MOUSE; NERVE CELL; NERVE CELL NETWORK; PATHOLOGY; ULTRASTRUCTURE;

AGING; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL COUNT; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE NET; NEURONS; RNA, MESSENGER; SYNAPTOPHYSIN;

EID: 0030612033     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199709000-00002     Document Type: Article

References (39)

1. Selkoe D. Alzheimer's disease: A central role for amyloid. J Neuropathol Exp Neural 1994;53:438-47
2. Koh J-Y, Yang L-L, Cotman CW. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990;533:315-20
3. Mattson MP, Cheng B, Davis D. Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992;12:379-89
4. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 1993;13:1676-87
5. Cotman CW, Whittemore ER, Watt JA, Anderson AJ, Loo DT. Possible role of apoptosis in Alzheimer's disease. Ann New York Acad Sci 1994;747:36-49
6. Yankner BA, Lorenzo A. Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann New York Acad Sci 1996;777:89-95
7. Games D, Khan KM, Soriano FG, Davis DL, Bryant K, Lieberburg I. Lack of Alzheimer pathology after β-amyloid protein injections in the brain. Neurobiol Aging 1992;13:569-76
8. Podlisny MB, Stephenson DT, Frosch MP, Lieberburg I, Clemens JA, Selkoe DJ. Synthetic β-amyloid protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol Aging 1992;13: 561-68
9. Stein-Beherns B, Adams K, Yen M, Sapolsky R. Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol Aging 1992;13:577-79
10. Hyman BT, Marzloff K, Arriagada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropath Exp Neurol 1993;52:594-600
11. Nagy Z, Esiri MM, Jobst KA. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: Correlations using three sets of neuropathological criteria. Dementia 1995;6:21-31
12. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E e4 in Alzheimer's disease. Ann Neurol 1996;39:62-70
13. Gomez-Isla T, Price J, McKeel D, Morris J, Growdon J, Hyman B. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-4500
14. Gomez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997;41:17-24
15. Hsiao K, Chapman P. Nilsen S, et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 1996;274:99-102
16. Sirinathsinghji DJS, Dunnett SB. Imaging gene expression in neural grafts. In: Sharif NA, ed. Molecular imaging in neuroscience: A practical approach. Oxford University Press: New York. 1993:43-70
17. Page K, Hollister R, Tanzi RE, Hyman BT. In situ hybridization analysis of presenilin 1 mRNA in Alzheimer's disease and in lesioned rat brain. Proc Natl Acad Sci USA 1996;93:14020-24
18. Sola C, Mengod G, Probst A, Palacios JM. Differential regional and cellular distribution of beta-amyloid precursor protein messenger RNAs containing and lacking the Kunitz protease inhibitor domain in the brain of human, rat and mouse. Neuroscience 1993;53: 267-95
19. Haass C, Schlossmacher MG, Hung AY, et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 1992;359:322-25
20. Weidemann A, Konig G, Bunke D, et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989;57:115-26
21. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD. Neurodegeneration in the central nervous system of apoE-deficient mice. Experimental Neurology 1995;136:107-22
22. West MJ, Gundersen HJG. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 1990;296:1-22
23. Cavalieri B. Geometria degli indivisibili. Torino: Unione Tipografico, Editrice. 1966
24. Douglas RJ. Spontaneous alternation behavior. Denber WN, Richman LL, eds. Springer-Verlag: New York. 1990:73-109
25. West MJ. Differences in the pattern of hippocampal neuron loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769-72
26. Clark AW, Parhad IM. Expression of neuronal mRNAs in Alzheimer type degeneration of the nervous system. Can J Neurol Sci 1989;16:477-82
27. Simonian NA, Hyman BT. Functional alterations in Alzheimer's disease: Selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J Neuropath Exp Neurol 1994;53:508-12
28. Callahan LM, Coleman PD. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol Aging 1995;16:311-14
29. de la Monte SM, Ng S-C, Hsu DW. Aberrant GAP-43 gene expression in Alzheimer's disease. Am J Pathol 1995;147:934-46
30. Hatanpaa K, Brady DR, Stoll J, Rapoport SI, Chandresekaran K. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1996;40:411-20
31. Wong-Riley MTT; Cytochrome oxidase: An endogenous metabolic marker of neuronal activity. Trends Neurosci 1989;12:94-101
32. Jones EG. The role of afferent activity in the maintenance of primate neocortical function. J Exp Biol 1990;153:155-76
33. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986;20:473-82
34. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 1994;174:67-72
35. Goate A, Chartier-Harlin M-C, Mullan M. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-7
36. Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nature Genetics 1992;1:345-47
37. Hsiao KK, Borchelt DR, Olson K, et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 1995;15:1203-18
38. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995;373:523-27
39. Irizarry MC, Soriano F, McNamara M, et al. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the PDAPP transgenic mice. J Neurosci 1997. Forthcoming.